Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Revenues: | ||||||
| Total revenues | $ 19,581,000 | $ 23,264,000 | $ 39,606,000 | $ 50,775,000 | ||
| Operating expenses: | ||||||
| Cost of revenues, including amortization | [1] | 3,976,000 | 4,948,000 | 8,129,000 | 11,932,000 | |
| Research and development | [1] | 1,580,000 | 2,267,000 | 3,622,000 | 5,370,000 | |
| Sales and marketing | [1] | 4,504,000 | 6,692,000 | 10,223,000 | 14,451,000 | |
| Editorial | [1] | 3,391,000 | 3,472,000 | 7,011,000 | 8,270,000 | |
| General and administrative | [1] | 9,231,000 | 11,378,000 | 18,735,000 | 27,676,000 | |
| Amortization of intangible assets | [1] | 1,889,000 | 1,934,000 | 3,782,000 | 4,265,000 | |
| Impairment of goodwill | [1] | 19,100,000 | 0 | 54,700,000 | 0 | |
| Total operating expenses | [1] | 43,671,000 | 30,691,000 | 106,202,000 | 71,964,000 | |
| Operating loss | (24,090,000) | (7,427,000) | (66,596,000) | (21,189,000) | ||
| Loss (gain) on sale of business (Note 3) | 0 | 319,000 | 0 | (15,424,000) | ||
| Interest expense, net | 3,904,000 | 4,338,000 | 7,260,000 | 9,465,000 | ||
| Change in fair value of financial instruments | (93,000) | 1,577,000 | (1,955,000) | 906,000 | ||
| Loss on debt extinguishment, net | 0 | 0 | 0 | 1,784,000 | ||
| Other (income) expense, net | 21,000 | 405,000 | (165,000) | 435,000 | ||
| Net loss before income taxes | (27,922,000) | (14,066,000) | (71,736,000) | (18,355,000) | ||
| Benefit from income taxes | (88,000) | (795,000) | (289,000) | (834,000) | ||
| Net loss | (27,834,000) | (13,271,000) | (71,447,000) | (17,521,000) | ||
| Other comprehensive income | 966,000 | 50,000 | 887,000 | 351,000 | ||
| Total comprehensive loss | (26,868,000) | (13,221,000) | (70,560,000) | (17,170,000) | ||
| Net loss used to compute basic loss per share | (27,834,000) | (13,271,000) | (71,447,000) | (17,521,000) | ||
| Net loss used to compute diluted loss per share | $ (27,834,000) | $ (13,271,000) | $ (71,447,000) | $ (17,521,000) | ||
| Loss per share attributable to common shareholders (Note 12): | ||||||
| Basic | $ (1.06) | $ (1) | $ (3.22) | $ (1.35) | ||
| Diluted | $ (1.06) | $ (1) | $ (3.22) | $ (1.35) | ||
| Weighted average shares used in computing loss per share attributable to common shareholders: | ||||||
| Basic | 26,145,210 | 13,333,374 | 22,217,096 | 12,972,412 | ||
| Diluted | 26,145,210 | 13,333,374 | 22,217,096 | 12,972,412 | ||
| Subscription | ||||||
| Revenues: | ||||||
| Total revenues | $ 18,800,000 | $ 21,380,000 | $ 37,853,000 | $ 46,612,000 | ||
| Non-subscription | ||||||
| Revenues: | ||||||
| Total revenues | $ 781,000 | $ 1,884,000 | $ 1,753,000 | $ 4,163,000 | ||
| ||||||
| X | ||||||||||
- Definition Change in fair value of financial instruments. No definition available.
|
| X | ||||||||||
- Definition Cost of revenues, including amortization. No definition available.
|
| X | ||||||||||
- Definition Editorial expense. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense for debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of other comprehensive income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|